Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 13.92% is 22% above its 5-year average of 11.44%, near the low end of its 5-year range (7.80%–28.81%).
As of the fiscal period ended Tuesday, June 30, 2026. 23.06% below its 12-month average of 18.09%.
Reported quarterly debt to assets ratio; no daily interpolation. Q3 FY2026 (2026-06-30): 13.92%.
DEBT TO ASSETS RATIO
13.92%
DEBT TO ASSETS RATIO AVG TTM
18.09%
DEBT TO ASSETS RATIO AVG 3Y
13.06%
DEBT TO ASSETS RATIO AVG 5Y
11.44%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-23.06%
CURRENT VS 3Y AVG
+6.58%
CURRENT VS 5Y AVG
+21.65%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+15364.48%
vs the sector median at left
Twist Bioscience Corporation
Market Cap
$10.40B
Debt to Assets Ratio
13.92%
TTM Avg
18.09%
3Y Avg
13.06%
5Y Avg
11.44%
Market Cap
$10.31B
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.19B
Debt to Assets Ratio
0.25%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.13B
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.72B
Debt to Assets Ratio
0.33%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.03B
Debt to Assets Ratio
0.39%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.87B
Debt to Assets Ratio
0.36%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Twist Bioscience Corporation (TWST) | $10.40B | 13.92% | 18.09% | 13.06% | 11.44% |
| Globus Medical, Inc. (GMED)vs › | $10.31B | 0.02% | N/A | N/A | N/A |
| 10x Genomics, Inc. (TXG)vs › | $10.24B | 0.08% | N/A | N/A | N/A |
| Molina Healthcare, Inc. (MOH)vs › | $10.19B | 0.25% | N/A | N/A | N/A |
| ImmunityBio, Inc. (IBRX)vs › | $10.15B | 1.29% | N/A | N/A | N/A |
| Align Technology, Inc. (ALGN)vs › | $10.13B | 0.02% | N/A | N/A | N/A |
| Universal Health Services, Inc. (UHS)vs › | $10.72B | 0.33% | N/A | N/A | N/A |
| The Ensign Group, Inc. (ENSG)vs › | $10.03B | 0.39% | N/A | N/A | N/A |
| BioMarin Pharmaceutical Inc. (BMRN)vs › | $10.87B | 0.36% | N/A | N/A | N/A |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.93B | 0.12% | N/A | N/A | N/A |
Debt/Assets
13.9%
Debt/Equity
0.21
Current Ratio
2.67
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 13.92% |
| 2026-03-31 | 14.17% |
| 2025-12-31 | 28.81% |
| 2025-09-30 | 21.39% |
| 2025-06-30 | 12.14% |
| 2025-03-31 | 13.48% |
| 2024-12-31 | 13.58% |
| 2024-09-30 | 13.84% |
| 2024-06-30 | 13.66% |
| 2024-03-31 | 12.72% |
| 2023-12-31 | 12.54% |
| 2023-09-30 | 12.12% |
| 2023-06-30 | 11.48% |
| 2023-03-31 | 10.68% |
| 2022-12-31 | 10.33% |
| 2022-09-30 | 9.87% |
| 2022-06-30 | 8.02% |
| 2022-03-31 | 7.80% |
| 2021-12-31 | 9.28% |
| 2021-09-30 | 8.96% |
| 2021-06-30 | 8.79% |
| 2021-03-31 | 4.71% |
| 2020-12-31 | 4.87% |
| 2020-09-30 | 9.02% |
| 2020-06-30 | 9.29% |
| 2020-03-31 | 12.50% |
| 2019-12-31 | 22.32% |
| 2019-09-30 | 4.14% |
| 2019-06-30 | 4.09% |
| 2019-03-31 | 6.54% |
| 2018-12-31 | 6.00% |
| 2018-09-30 | 8.39% |
| 2018-06-30 | 7.77% |
| 2017-09-30 | 10.69% |
